Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Demyelination and other neurological adverse events after anti-TNF therapy.
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases.
The visual pathway as a model to understand brain damage in multiple sclerosis.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
Exploring the potential of public proteomics data.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012).
[Compensatory mechanisms in multiple sclerosis(review)].
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.
Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis.
Correction: The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting Multiple Sclerosis who Received Genzyme’s Lemtrada® (alemtuzumab) in Clinical Trials

Pages